【产品介绍】：

中文别名 头孢氨苄 英文别名 Cephalexin CAS号 15686-71-2 SMILES [H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O Inchi InChI=1S/C16H17N3O4S/c1-8-7-24-15-11(14(21)19(15)12(8)16(22)23)18-13(20)10(17)9-5-3-2-4-6-9/h2-6,10-11,15H,7,17H2,1H3,(H,18,20)(H,22,23)/t10-,11-,15-/m1/s1 InchiKey CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O 分子式 Formula C16H17N3O4S 分子量 Molecular Weight 347.389 闪点 FP NA 熔点 Melting point NA 沸点 Boiling point NA Polarizability极化度 3 密度 Density NA 蒸汽压 Vapor Pressure 溶解度Solubility 性状 NA 储藏条件 Storage conditions Cephalexin使用注意事项：1.实验前需戴好防护眼镜，穿戴防护服和口罩，佩戴手套，避免与皮肤接触。2.实验过程中如遇到有毒或者刺激性物质及有害物质产生，必要时实验操作需要手套箱内完成以免对实验人员造成伤害。3.取样品的移液枪头需及时更换，必要时为避免交叉污染尽可能选择滤芯吸头。4.称量药品时选用称量纸，并无风处取药和称量以免扬撒，试剂的容器使用前务必确保干净，并消毒。5.取药品时尽量采用多个药勺分别使用，使用后清洗干净。6.实验后产生的废弃物需分类存储，并交于专业生物废气物处理公司处理，以免造成环境污染。大规格定制：定制产品请将信息发送至sales@bio-fount.com。Experimental considerations: 1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment. 2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution. 产品说明 This compound belongs to the class of organic compounds known as cephalosporins. These are compounds containing a 1,2-thiazine fused to a 2-azetidinone to for a oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid moiety or a derivative thereof. IntroductionFor the treatment of hypertension. Application1Cephalexin is indicated for the treatment of certain infections caused by susceptible bacteria.Label,12,13These infections include respiratory tract infections, otitis media, skin and skin structure infections, bone infections, and genitourinary tract infections.Label,12,13 Application2Inhibitor Application3Inhibitor Cephalexin is the first of the first generation cephalosporins. This antibiotic contains a beta lactam and a dihydrothiazide. Cephalexin is used to treat a number of susceptible bacterial infections through inhibition of cell wall synthesis. Cephalexin was approved by the FDA on 4 January 1971. 警示图 危险性 危险性警示 warning 安全声明 H317 (100%): May cause an allergic skin reaction [Warning Sensitization, Skin] H334 (100%): May cause allergy or asthma symptoms or breathing difficulties if inhaled [Danger Sensitization, respiratory] 安全防护 备注 实验过程中防止吸入、食如，做好安全防护 对不起，暂无产品评价！